NCT00002201View on ClinicalTrials.gov

A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patients

NACompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Ritonavir

DRUG

Nelfinavir mesylate

Trial Locations (1)

21287

Johns Hopkins Hosp, Baltimore

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY

NCT00002201 - A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patients | Biotech Hunter | Biotech Hunter